应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AORT Artivion
已收盘 05-09 16:00:00 EDT
23.40
+0.10
+0.43%
盘后
23.40
+0.00
0.00%
19:20 EDT
最高
23.84
最低
23.14
成交量
21.34万
今开
23.25
昨收
23.30
日振幅
3.00%
总市值
9.77亿
流通市值
8.13亿
总股本
4,174万
成交额
500.75万
换手率
0.61%
流通股本
3,474万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Artivion, Inc.盘中异动 快速上涨19.32%报25.14美元
自选股智能写手 · 05-07 21:32
Artivion, Inc.盘中异动 快速上涨19.32%报25.14美元
Artivion Inc 预计每股亏损11美分 - 财报前瞻
Reuters · 05-04
Artivion Inc 预计每股亏损11美分 - 财报前瞻
Artivion, Inc.盘中异动 股价大涨5.05%报20.61美元
自选股智能写手 · 05-02
Artivion, Inc.盘中异动 股价大涨5.05%报20.61美元
Artivion, Inc.盘中异动 大幅下跌5.10%报19.85美元
自选股智能写手 · 04-25
Artivion, Inc.盘中异动 大幅下跌5.10%报19.85美元
Artivion, Inc.盘中异动 大幅上涨5.02%
自选股智能写手 · 03-28
Artivion, Inc.盘中异动 大幅上涨5.02%
Artivion Inc2023财年实现净利润-30.69百万美元,同比减少60.76%
自选股智能写手 · 02-19
Artivion Inc2023财年实现净利润-30.69百万美元,同比减少60.76%
美国研究综述-阿尔伯马尔、Dropbox、英伟达
Reuters · 02-16
美国研究综述-阿尔伯马尔、Dropbox、英伟达
Artivion Inc 报告截至 12 月的季度业绩 - 收益摘要
Reuters · 02-16
Artivion Inc 报告截至 12 月的季度业绩 - 收益摘要
Artivion Inc 预计每股亏损10美分 - 财报前瞻
Reuters · 02-14
Artivion Inc 预计每股亏损10美分 - 财报前瞻
Artivion Inc盘中异动 早盘股价大涨5.01%
自选股智能写手 · 2023-11-24
Artivion Inc盘中异动 早盘股价大涨5.01%
Artivion Inc盘中异动 早盘快速上涨5.07%报16.68美元
自选股智能写手 · 2023-11-23
Artivion Inc盘中异动 早盘快速上涨5.07%报16.68美元
Artivion Inc盘中异动 急速拉升15.44%报16.30美元
自选股智能写手 · 2023-11-21
Artivion Inc盘中异动 急速拉升15.44%报16.30美元
Artivion Inc盘中异动 股价大涨5.12%报14.27美元
自选股智能写手 · 2023-11-14
Artivion Inc盘中异动 股价大涨5.12%报14.27美元
Artivion Inc2023财年第三财季实现净利润-9.76百万美元,同比增加28.45%
自选股智能写手 · 2023-11-12
Artivion Inc2023财年第三财季实现净利润-9.76百万美元,同比增加28.45%
加载更多
公司概况
公司名称:
Artivion
所属市场:
NYSE
上市日期:
--
主营业务:
Artivion, Inc.于 1984 年在佛罗里达州注册成立,并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州,是生产,加工和分销医疗器械和植入式人体组织的领先企业,专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列:BioGlue外科胶粘剂(“BioGlue”); On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心脏贴片(“CryoPatch SG”)在内的心脏和血管人体组织,两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法,PerClot和PhotoFixTM。
发行价格:
--
{"stockData":{"symbol":"AORT","market":"US","secType":"STK","nameCN":"Artivion","latestPrice":23.4,"timestamp":1715284800000,"preClose":23.3,"halted":0,"volume":213447,"hourTrading":{"tag":"盘后","latestPrice":23.4,"preClose":23.4,"latestTime":"19:20 EDT","volume":5009,"amount":117209.14,"timestamp":1715296835549},"delay":0,"floatShares":34741782,"shares":41737000,"eps":-0.231996,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1,"latestTime":"05-09 16:00:00 EDT","open":23.25,"high":23.84,"low":23.14,"amount":5007472.596516,"amplitude":0.030043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.231996,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"listingDate":868939200000,"adjPreClose":23.3,"preHourTrading":{"tag":"盘前","latestPrice":23.78,"preClose":23.3,"latestTime":"08:00 EDT","volume":1,"amount":23.78,"timestamp":1715256000234},"postHourTrading":{"tag":"盘后","latestPrice":23.4,"preClose":23.4,"latestTime":"19:20 EDT","volume":5009,"amount":117209.14,"timestamp":1715296835549},"volumeRatio":0.617505},"requestUrl":"/m/hq/s/AORT","defaultTab":"news","newsList":[{"id":"2433207701","title":"Artivion, Inc.盘中异动 快速上涨19.32%报25.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433207701","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433207701?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:32","pubTimestamp":1715088776,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时32分,Artivion, Inc.股票出现波动,股价快速上涨19.32%。截至发稿,该股报25.14美元/股,成交量7.2862万股,换手率0.17%,振幅10.82%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为0.34%。其相关个股中,Nuwellis, Inc.、Artivion, Inc.、Bioventus Inc.涨幅较大,Nuwellis, Inc.、Helius Medical Technologies, Inc.、Ainos, Inc.较为活跃,换手率分别为263.65%、30.13%、6.98%,振幅较大的相关个股有Nuwellis, Inc.、Artivion, Inc.、Holdco Nuvo Group D.G Ltd.,振幅分别为31.93%、12.60%、8.57%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721325687dc9e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721325687dc9e60&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432915323","title":"Artivion Inc 预计每股亏损11美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432915323","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432915323?lang=zh_cn&edition=full","pubTime":"2024-05-04 06:14","pubTimestamp":1714774485,"startTime":"0","endTime":"0","summary":" * Artivion公司 将于5月6日公布截至2001年1月1日的业绩报告,预计该公司的季度收入将有所增长。* 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于佐治亚州肯尼索的公司的营收有望从去年同期的8323万美元增长10.5%,达到9197.8万美元。* LSEG 分析师对 Artivion Inc 的平均预期为每股亏损 11 美分。* 华尔街对 Artivion Inc 的 12 个月目标价中位数为 25.00 美元,高于其最新收盘价 20.93 美元。5月3日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432524638","title":"Artivion, Inc.盘中异动 股价大涨5.05%报20.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432524638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432524638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:39","pubTimestamp":1714588776,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时39分,Artivion, Inc.股票出现波动,股价快速上涨5.05%。截至发稿,该股报20.61美元/股,成交量6.9165万股,换手率0.17%,振幅6.17%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为0.10%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502023936861ea91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502023936861ea91d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430511284","title":"Artivion, Inc.盘中异动 大幅下跌5.10%报19.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430511284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430511284?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:07","pubTimestamp":1714054058,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时07分,Artivion, Inc.股票出现异动,股价急速下挫5.10%。截至发稿,该股报19.85美元/股,成交量9246股,换手率0.02%,振幅3.15%。Artivion, Inc.股票所在的医疗器械行业中,整体跌幅为1.05%。其相关个股中,Bluejay Diagnostics, Inc.、Thermogenesis Holdings, Inc.、Nuwellis, Inc.涨幅较大,Nuwellis, Inc.、Sintx Technologies, Inc.、Invo Bioscience, Inc.较为活跃,换手率分别为61.24%、4.08%、3.52%,振幅较大的相关个股有Bluejay Diagnostics, Inc.、Nuwellis, Inc.、Lensar, Inc.,振幅分别为23.26%、15.07%、10.43%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252207387a55b6b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252207387a55b6b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422947868","title":"Artivion, Inc.盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422947868","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422947868?lang=zh_cn&edition=full","pubTime":"2024-03-28 02:32","pubTimestamp":1711564348,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日02时32分,Artivion, Inc.股票出现波动,股价快速上涨5.02%。截至发稿,该股报21.56美元/股,成交量9.6655万股,换手率0.23%,振幅4.38%。Artivion, Inc.股票所在的医疗器械行业中,整体涨幅为1.65%。Artivion, Inc.公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280232297a4f8eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280232297a4f8eea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412102997","title":"Artivion Inc2023财年实现净利润-30.69百万美元,同比减少60.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412102997","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412102997?lang=zh_cn&edition=full","pubTime":"2024-02-19 00:22","pubTimestamp":1708273343,"startTime":"0","endTime":"0","summary":"12月31日,Artivion Inc公布财报,公告显示公司2023财年净利润为-30.69百万美元,同比减少60.76%;其中营业收入为3.54亿美元,同比增加12.74%,每股基本收益为-0.75美元。机构评级:截至2023年12月31日,当前有5家机构对Artivion Inc目标价做出预测,其中目标均价为25.15美元,其中最低目标价为22.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219002232879e46d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219002232879e46d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":" 路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp :摩根大通将目标价从130美元下调至115美元 * Bloom Energy Corp :KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp :奥本海默将目标价从650美元上调至850美元 * Tyler Technologies Inc :Piper Sandler将目标价从480美元上调至520美元 以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411775865","title":"Artivion Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2411775865","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411775865?lang=zh_cn&edition=full","pubTime":"2024-02-16 06:45","pubTimestamp":1708037123,"startTime":"0","endTime":"0","summary":" * Artivion Inc 报告,截至12月底的季度调整后每股亏损10美分,低于去年同期的每股收益5美分。五位分析师对该季度的平均预期是每股亏损 10 美分。华尔街预期为每股-22美分至-4美分。* 营收同比增长 18%,达到 9367 万美元;分析师预期为 8929 万美元。* Artivion Inc公布的本季度每股收益为亏损10美分。* 该公司当季亏损 398 万美元。* 本季度,Artivion Inc 的股价下跌了 1.8%。华尔街对 Artivion Inc 的 12 个月目标价中位数为 25.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411397779","title":"Artivion Inc 预计每股亏损10美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411397779","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411397779?lang=zh_cn&edition=full","pubTime":"2024-02-14 05:38","pubTimestamp":1707860296,"startTime":"0","endTime":"0","summary":" * Artivion公司 将于2月15日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于佐治亚州肯尼索的公司的营收有望从去年同期的7940万美元增长12.5%,达到8928.7万美元。 * LSEG 分析师对 Artivion Inc 的平均预期是每股亏损 10 美分。* 华尔街对 Artivion Inc 的 12 个月目标价中位数为 25.00 美元,高于其最新收盘价 17.59 美元。2月13日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2385536289","title":"Artivion Inc盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385536289","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385536289?lang=zh_cn&edition=full","pubTime":"2023-11-24 23:02","pubTimestamp":1700838126,"startTime":"0","endTime":"0","summary":"北京时间2023年11月24日23时02分,Artivion Inc股票出现异动,股价急速上涨5.01%。Artivion Inc股票所在的医疗器械行业中,整体涨幅为0.38%。其相关个股中,Modular Medical Inc、Sight Sciences Inc、Telesis Bio Inc涨幅较大,Telesis Bio Inc、Heart Test Laboratories Inc、Invo Bioscience Inc较为活跃,换手率分别为14.03%、6.96%、5.68%,振幅较大的相关个股有Telesis Bio Inc、Modular Medical Inc、Sight Sciences Inc,振幅分别为26.53%、25.45%、18.00%。Artivion Inc公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112423020683080b6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112423020683080b6a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2385665158","title":"Artivion Inc盘中异动 早盘快速上涨5.07%报16.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2385665158","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385665158?lang=zh_cn&edition=full","pubTime":"2023-11-23 00:05","pubTimestamp":1700669122,"startTime":"0","endTime":"0","summary":"北京时间2023年11月23日00时05分,Artivion Inc股票出现异动,股价大幅上涨5.07%。截至发稿,该股报16.68美元/股,成交量13.4383万股,换手率0.33%,振幅5.14%。Artivion Inc股票所在的医疗器械行业中,整体涨幅为0.80%。Artivion Inc公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123000522847633f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123000522847633f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2385520314","title":"Artivion Inc盘中异动 急速拉升15.44%报16.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2385520314","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385520314?lang=zh_cn&edition=full","pubTime":"2023-11-21 22:33","pubTimestamp":1700577180,"startTime":"0","endTime":"0","summary":"北京时间2023年11月21日22时33分,Artivion Inc股票出现异动,股价大幅上涨15.44%。Artivion Inc股票所在的医疗器械行业中,整体涨幅为0.48%。其相关个股中,Nanovibronix Inc、Artivion Inc、Invo Bioscience Inc涨幅较大,Invo Bioscience Inc、Heart Test Laboratories Inc、Reshape Lifesciences Inc较为活跃,换手率分别为25.92%、8.55%、7.87%,振幅较大的相关个股有Ainos Inc、Heart Test Laboratories Inc、Vicarious Surgical Inc,振幅分别为8.80%、8.27%、6.64%。Artivion Inc公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112122330081f7e112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112122330081f7e112&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383724042","title":"Artivion Inc盘中异动 股价大涨5.12%报14.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2383724042","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383724042?lang=zh_cn&edition=full","pubTime":"2023-11-14 22:37","pubTimestamp":1699972642,"startTime":"0","endTime":"0","summary":"北京时间2023年11月14日22时37分,Artivion Inc股票出现波动,股价大幅拉升5.12%。截至发稿,该股报14.27美元/股,成交量1854股,换手率0.00%,振幅0.00%。Artivion Inc股票所在的医疗器械行业中,整体涨幅为1.66%。Artivion Inc公司简介:Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111422372282745f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111422372282745f52&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382794090","title":"Artivion Inc2023财年第三财季实现净利润-9.76百万美元,同比增加28.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382794090","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382794090?lang=zh_cn&edition=full","pubTime":"2023-11-12 00:21","pubTimestamp":1699719675,"startTime":"0","endTime":"0","summary":"9月30日,Artivion Inc公布财报,公告显示公司2023财年第三财季净利润为-9.76百万美元,同比增加28.45%;其中营业收入为87.85百万美元,同比增加14.33%,每股基本收益为-0.24美元。从资产负债表来看,Artivion Inc总负债5.03亿美元,其中短期债务6.02百万美元,资产负债比为1.55,流动比率为0.04。机构评级:截至2023年9月30日,当前有5家机构对Artivion Inc目标价做出预测,其中目标均价为24.15美元,其中最低目标价为20.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311120021248408865e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311120021248408865e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivion.com","stockEarnings":[{"period":"1week","weight":0.1461},{"period":"1month","weight":0.0767},{"period":"3month","weight":0.3714},{"period":"6month","weight":0.7479},{"period":"1year","weight":0.585},{"period":"ytd","weight":0.3031}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artivion, Inc.于 1984 年在佛罗里达州注册成立,并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州,是生产,加工和分销医疗器械和植入式人体组织的领先企业,专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列:BioGlue外科胶粘剂(“BioGlue”); On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心脏贴片(“CryoPatch SG”)在内的心脏和血管人体组织,两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法,PerClot和PhotoFixTM。","yearOnYearQuotes":[{"month":1,"riseRate":0.419355,"avgChangeRate":0.008271},{"month":2,"riseRate":0.516129,"avgChangeRate":0.012},{"month":3,"riseRate":0.40625,"avgChangeRate":-0.009697},{"month":4,"riseRate":0.625,"avgChangeRate":0.069648},{"month":5,"riseRate":0.5,"avgChangeRate":0.058361},{"month":6,"riseRate":0.645161,"avgChangeRate":0.031008},{"month":7,"riseRate":0.516129,"avgChangeRate":-0.005333},{"month":8,"riseRate":0.483871,"avgChangeRate":0.010236},{"month":9,"riseRate":0.677419,"avgChangeRate":0.037253},{"month":10,"riseRate":0.387097,"avgChangeRate":-0.034117},{"month":11,"riseRate":0.516129,"avgChangeRate":0.013449},{"month":12,"riseRate":0.548387,"avgChangeRate":0.025286}],"exchange":"NYSE","name":"Artivion","nameEN":"Artivion"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artivion,AORT,Artivion股票,Artivion股票老虎,Artivion股票老虎国际,Artivion行情,Artivion股票行情,Artivion股价,Artivion股市,Artivion股票价格,Artivion股票交易,Artivion股票购买,Artivion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}